It also enhances the interaction between the E3 ubiquitin ligase β-TrCP1 and HuR, making HuR more susceptible to ubiquitination and degradation (36), which in turn reduces the levels of HuR and its target mRNAs, including those directly associated with cancer cell growth. Here, ELAVL1 is linked to cancer.